Get started
Author

Deddo Moertl

Observed names: D MOERTL, D Moertl, D. Moertl, Moertl, Deddo
Observed institutions: University of Vienna, TU Wien, Vienna General Hospital, Ludwig Boltzmann Institute for Cardiovascular Research, Universitätsklinikum St. Pölten, Karl Landsteiner University of Health Sciences, Karl Landsteiner Society, Medical University of Vienna
ORCID: 0000-0001-6408-8978
Observed ORCID: 0000-0001-6408-8978
OpenAlex ID: A5010355045
Empagliflozin in acute myocardial infarction: the EMMY trial
2022 · Dirk von Lewinski, Ewald Kolesnik, et al. · European Heart Journal · 330
Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis
2014 · R. W. Troughton, C. M. Frampton, et al. · European Heart Journal · 277
PDF
Comparison of Copeptin, B-Type Natriuretic Peptide, and Amino-Terminal Pro-B-Type Natriuretic Peptide in Patients With Chronic Heart Failure
2008 · Stephanie Neuhold, Martin Huelsmann, et al. · Journal of the American College of Cardiology · 238
PDF
N-Terminal Pro–B-Type Natriuretic Peptide–Guided, Intensive Patient Management in Addition to Multidisciplinary Care in Chronic Heart Failure
2010 · Rudolf Berger, Deddo Moertl, et al. · Journal of the American College of Cardiology · 234
A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction
2022 · Sunil V. Rao, Bodo Kirsch, et al. · Circulation · 182
PDF
Dose-dependent effects of omega-3-polyunsaturated fatty acids on systolic left ventricular function, endothelial function, and markers of inflammation in chronic heart failure of nonischemic origin
2011 · Deddo Moertl, Alexandra Hammer, et al. · American Heart Journal · 124
Stereolithographic biomodeling to create tangible hard copies of cardiac structures from echocardiographic data
2000 · Thomas M Binder, Deddo Moertl, et al. · Journal of the American College of Cardiology · 115
PDF
Comparison of Midregional Pro-Atrial and B-Type Natriuretic Peptides in Chronic Heart Failure
2009 · Deddo Moertl, Rudolf Berger, et al. · Journal of the American College of Cardiology · 102
PDF
N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients*
2007 · Brigitte Meyer, Martin Huelsmann, et al. · Critical Care Medicine · 99
Which Heart Failure Patients Profit from Natriuretic Peptide Guided Therapy? a Meta-Analysis from Individual Patient Data of Randomized Trials
2015 · Hans-Peter Brunner-La Rocca, Luc Eurlings, et al. · European Journal of Heart Failure · 96
PDF
ESC Core Curriculum for the Cardiologist
2020 · Felix C Tanner, Nicolas Brooks, et al. · European Heart Journal · 95
NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus
2008 · M. Huelsmann, S. Neuhold, et al. · European Heart Journal · 86
Impact of EMpagliflozin on cardiac function and biomarkers of heart failure in patients with acute MYocardial infarction—The EMMY trial
2019 · Norbert J Tripolt, Ewald Kolesnik, et al. · American Heart Journal · 73
Disease management programs in chronic heart failure: Position statement of the Heart Failure Working Group and the Working Group of the Cardiological Assistance and Care Personnel of the Austrian Society of Cardiology
2017 · Deddo Moertl, Johann Altenberger, et al. · Wiener klinische Wochenschrift · 54
PDF
Artificial neural networks and spatial temporal contour linking for automated endocardial contour detection on echocardiograms: a novel approach to determine left ventricular contractile function
1999 · Thomas Binder, Michael Süssner, et al. · Ultrasound in Medicine & Biology · 50
Assessing coronary stenosis. Quantitative coronary angiography versus visual estimation from cine-film or pharmacological stress perfusion images
1996 · M. Gottsauner-Wolf, H. Sochor, et al. · European Heart Journal · 50
Levosimendan and Prostaglandin E1 for Uptitration of Beta-Blockade in Patients with Refractory, Advanced Chronic Heart Failure
2006 · Rudolf Berger, Deddo Moertl, et al. · European Journal of Heart Failure · 49
PDF
Cost analysis and cost-effectiveness of NT-proBNP-guided heart failure specialist care in addition to home-based nurse care
2010 · Christopher Adlbrecht, Martin Huelsmann, et al. · European Journal of Clinical Investigation · 48
Short-Term Effects of Levosimendan and Prostaglandin E1 on Hemodynamic Parameters and B-Type Natriuretic Peptide Levels in Patients with Decompensated Chronic Heart Failure
2005 · Deddo Moertl, Rudolf Berger, et al. · European Journal of Heart Failure · 43
Pulmonary Artery Pulse Wave Velocity in Idiopathic Pulmonary Arterial Hypertension
2012 · Grzegorz Kopeć, Deddo Moertl, et al. · Canadian Journal of Cardiology · 42
Network meta-analysis of prasugrel, ticagrelor, high- and standard-dose clopidogrel in patients scheduled for percutaneous coronary interventions
2012 · Deddo Moertl, Li Chen, et al. · Thrombosis and Haemostasis · 40
Endothelial Markers May Link Kidney Function to Cardiovascular Events in Type 2 Diabetes
2009 · Christina Maier, Martin Clodi, et al. · Diabetes Care · 40
PDF
Cost-utility Analysis of Nt-probnp-guided Multidisciplinary Care in Chronic Heart Failure
2012 · Deddo Moertl, Sabine Steiner, et al. · International Journal of Technology Assessment in Health Care · 38
Low-density lipoprotein cholesterol and survival in pulmonary arterial hypertension
2017 · Grzegorz Kopeć, Marcin Waligóra, et al. · Scientific Reports · 36
PDF
Ertugliflozin to reduce arrhythmic burden in ICD/CRT patients (ERASe-trial) – A phase III study
2022 · Dirk von Lewinski, Norbert J Tripolt, et al. · American Heart Journal · 34
PDF
Works count: 114
Citation count: 3,033
H-index: 27
I10-index: 45
Year
Topic
Type